Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

December 31, 2009

Conditions
Hypertension
Interventions
DRUG

Olmesartan medoxomil

40mg olmesartan medoxomil

DRUG

Amlodipine

Amlodipine 10mg

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 25mg

Trial Locations (232)

Unknown

Birmingham

Columbiana

Gulf Shores

Hoover

Huntsville

Mobile

Montgomery

Muscle Shoals

Tuscumbia

Chandler

Goodyear

Lake Havasu City

Mesa

Peoria

Phoenix

Scottsdale

Tucson

Hot Springs

Jonesboro

Little Rock

North Little Rock

Searcy

Anaheim

Beverly Hills

Buena Park

Burbank

Carmichael

Chino

Chula Vista

Escondido

Greenbrae

Hollywood

Huntington Park

Long Beach

Los Angeles

Los Gatos

Merced

National City

Orange

Roseville

San Diego

San Jose

Santa Ana

Santa Monica

Temecula

West Palm Beach

Westlake Village

Denver

Golden

Pueblo

Wheat Ridge

Danbury

Milford

Stamford

Trumbull

Waterbury

Aventura

Boynton Beach

Bradenton

Brooksville

Cape Coral

Clearwater

Coral Gables

Crystal River

Daytona Beach

Deerfield Beach

DeLand

Delray Beach

Dunnellon

Fort Myers

Hialeah

Hollywood

Jacksonville

Jupiter

Kissimmee

Largo

Merritt Island

Miami

New Port Richey

Ocala

Palm Harbor

Pembroke Pines

Plantation

Port Orange

Sarasota

South Miami

St. Petersburg

Tampa

West Bradenton

Atlanta

Augusta

Columbus

Savannah

Suwanee

Waycross

Idaho Falls

Chicago

Gurnee

Libertyville

Evansville

Indianapolis

Newton

Shawnee Mission

Wichita

Madisonville

Mount Sterling

Munfordville

Paducah

Kenner

Lake Charles

Metairie

New Orleans

Shreveport

Baltimore

Elkridge

Oxon Hill

Brockton

Haverhill

West Yarmouth

Benzonia

Clarkston

Paw Paw

Southfield

Traverse City

Waterford

Brooklyn Center

Chaska

Saint Paul

Olive Branch

Florissant

Kansas City

St Louis

Butte

Missoula

Broken Bow

North Platte

Las Vegas

Berlin

Elizabeth

Voorhees Township

Buffalo

Manlius

Mineola

New York

Westfield

Calabash

Charlotte

Durham

Hickory

High Point

Raleigh

Salisbury

Statesville

Tabor City

Winston-Salem

Fargo

Austintown

Cincinnati

Cleveland

Columbus

Euclid

Franklin

Kettering

Lyndhurst

Marion

Mount Gilead

Wadsworth

Westlake

Norman

Oklahoma City

Tulsa

Eugene

Medford

Portland

Beaver

Bensalem

Downingtown

Erie

Harleysville

Jenkintown

Jersey Shore

Penndel

Philadelphia

Cranston

East Providence

Providence

Anderson

Charleston

Columbia

Murrells Inlet

Orangeburg

Rapid City

Bristol

Fayetteville

Knoxville

Memphis

Nashville

New Tazewell

Tullahoma

Austin

Bedford

Corpus Christi

Houston

Hurst

Lake Jackson

Midland

Plano

Round Rock

San Antonio

Spring

Sugar Land

Temple

Waco

Bountiful

Magna

Midvale

Salt Lake City

Sandy City

Saratoga Springs

West Jordan

Norfolk

Richmond

Suffolk

Federal Way

Lakewood

Tacoma

Kenosha

Madison

Ciales

Guayama

Ponce

Rio Piedras

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00649389 - Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension | Biotech Hunter | Biotech Hunter